Even in Death, This Glioblastoma Patient’s Selfless Lego Donation Drive Touches Thousands of Lives
source: pixabay.com

Even in Death, This Glioblastoma Patient’s Selfless Lego Donation Drive Touches Thousands of Lives

According to a story from 10tv.com, Kellan Shatto is an eight year old boy who really likes to play with Legos. He also has a rare disease: neurofibromatosis. The disease…

Continue Reading Even in Death, This Glioblastoma Patient’s Selfless Lego Donation Drive Touches Thousands of Lives
Zotiraciclib, a New Treatment for Glioma, is Granted Orphan Drug Designation
Source: Pixabay.com

Zotiraciclib, a New Treatment for Glioma, is Granted Orphan Drug Designation

  The European Organization for Research and Treatment of Cancer (EORTC) has been evaluating zotiraciclib, which is a new treatment for glioma. This drug has recently been granted the Orphan…

Continue Reading Zotiraciclib, a New Treatment for Glioma, is Granted Orphan Drug Designation
Recent Study Confirms Validity of the Therapeutic Target of an Experimental Brain Cancer Drug
sbtlneet / Pixabay

Recent Study Confirms Validity of the Therapeutic Target of an Experimental Brain Cancer Drug

According to a story from BioSpace, Oncotelic, Inc., recently announced the publication of a study in the Journal of Clinical Research in Pediatrics. This study appears to back up the therapeutic…

Continue Reading Recent Study Confirms Validity of the Therapeutic Target of an Experimental Brain Cancer Drug

Glioblastoma Clinical Trial: The Henry Ford Cancer Institute Enrolls the World’s First Glioblastoma Patient

  According to a recent article in CheckOrphan, glioblastoma (GBM) is considered to be among the deadliest cancers in the world. Currently, treatment options are surgery, chemotherapy, and radiation. In most cases,…

Continue Reading Glioblastoma Clinical Trial: The Henry Ford Cancer Institute Enrolls the World’s First Glioblastoma Patient
Glioblastoma “Vaccine” Yields Hopeful Results at End of Phase 1b Trial
source: pixabay.com

Glioblastoma “Vaccine” Yields Hopeful Results at End of Phase 1b Trial

According to a publication from EurekAlert, results from a phase 1b clinical study of experimental glioblastoma “vaccine“ IGV-001 suggest that the treatment is well tolerated in humans. Additional data collected…

Continue Reading Glioblastoma “Vaccine” Yields Hopeful Results at End of Phase 1b Trial
Korean Research Team Pioneers Method That Could Personalize Treatment for Glioblastoma
HeungSoon / Pixabay

Korean Research Team Pioneers Method That Could Personalize Treatment for Glioblastoma

According to a story from Korean Biomedical Review, a team of researchers from Seoul National University, headed by professor Paek Sun-ha, have developed an approach utilizing 3D cell printing technology…

Continue Reading Korean Research Team Pioneers Method That Could Personalize Treatment for Glioblastoma

GAPVAC Project Tests An Individualized Form of  Immunotherapy to Treat Aggressive Brain Cancer

A recent article in the journal Nature reports that Phase 1 GAPVAC-101 First-In-Human trial is one of the first clinical trials with a goal of designing and manufacturing actively personalized vaccines…

Continue Reading GAPVAC Project Tests An Individualized Form of  Immunotherapy to Treat Aggressive Brain Cancer

Oregon Health & Science University to Participate in Study to Predict Treatment Response for Rare Cancer

According to a story from IT Business Net, the medical company KIYATEC, Inc., has recently announced that that the Knight Cancer Institute at Oregon Health & Science University has joined…

Continue Reading Oregon Health & Science University to Participate in Study to Predict Treatment Response for Rare Cancer
The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma
johnhain / Pixabay

The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma

According to a story from pm360online.com, The National Brain Tumor Society (NBTS) recently awarded $750,000 to the Global Coalition for Adaptive Research. This cash is slated to go towards the…

Continue Reading The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma

Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit

Notable Labs Notable Labs was created after founder, Matt De Silva, felt he was left in a helpless point, following a year of research on treatment options for his father's Glioblastoma…

Continue Reading Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit
Research Indicates Sex Differences Affect Response to Cancer Treatment
https://pixabay.com/en/hands-heart-couple-woman-man-1150073/

Research Indicates Sex Differences Affect Response to Cancer Treatment

For a long time, we've known that, at least in North America, men develop cancer at higher rates than women. However, there is still some mystery concerning the impact of…

Continue Reading Research Indicates Sex Differences Affect Response to Cancer Treatment
A Mother With Deadly Glioblastoma is Using Her Remaining Time to Make Memories With Her Kids
jarmoluk / Pixabay

A Mother With Deadly Glioblastoma is Using Her Remaining Time to Make Memories With Her Kids

According to a story from liverpoolecho.co.uk, Isabel Morison is a 39-year-old music teacher with a nine year old son Dylan and a six year old daughter, Lucy. Last March, she…

Continue Reading A Mother With Deadly Glioblastoma is Using Her Remaining Time to Make Memories With Her Kids
Close Menu